06.07.2017 - JSR Life Sciences has acquired Swiss biotech Selexis for an undisclosed sum. The Geneva-headquartered company is the global leader in mammalian cell-line generation technologies...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)
